Search

everythinglearnresearchcommunity

for

Search:↓

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

3% topical minoxidil effectively treats extensive alopecia areata with few side effects.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Both genetic and lifestyle factors significantly affect female hair loss.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

PRP did not significantly regrow hair in alopecia areata totalis patients.